Starpharma Holdings Ltd Total Liabilities

Latest as of June 2026: AU$5.24 Million AUD ≈ $3.71 Million USD

Starpharma Holdings Ltd total liabilities. Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has total liabilities worth AU$5.24 Million AUD (≈ $3.71 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SPL financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Starpharma Holdings Ltd (2000–2026)

Total liabilities of Starpharma Holdings Ltd from 2000 to 2026. This chart illustrates how Starpharma Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data.

Starpharma Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of Starpharma Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Invesco Trust For Inv Grade NY Munis NYSE:VTN	USA	$78.55 Million
Segro Plc LSE:SGRO	UK	GBX6.04 Billion
Centrum Medyczne ENEL-MED SA WAR:ENE	Poland	zł466.54 Million
Seven Hills Realty Trust NASDAQ:SEVN	USA	$474.45 Million
Polytronics Technology Corp TW:6224	Taiwan	NT$1.79 Billion
Powerwell Holdings Bhd KLSE:0217	Malaysia	RM68.20 Million
Intelligent Monitoring Group Ltd AU:IMB	Australia	AU$157.42 Million
Genovis AB (publ.) ST:GENO	Sweden	Skr106.41 Million

Liability Composition Analysis (2000–2026)

This chart breaks down Starpharma Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SPL current and non-current assets.

Liquidity & Leverage Metrics

Starpharma Holdings Ltd Total Liabilities Ratios Explained

Starpharma Holdings Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Starpharma Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Starpharma Holdings Ltd (2000–2026)

The table below shows the annual total liabilities of Starpharma Holdings Ltd from 2000 to 2026.

Year	Total Liabilities	Change
2026-06-30	AU$5.24 Million ≈ $3.71 Million	-18.40%
2025-06-30	AU$6.42 Million ≈ $4.54 Million	-26.16%
2024-06-30	AU$8.70 Million ≈ $6.15 Million	-49.64%
2023-06-30	AU$17.27 Million ≈ $12.22 Million	-2.87%
2022-06-30	AU$17.78 Million ≈ $12.58 Million	+62.57%
2021-06-30	AU$10.94 Million ≈ $7.74 Million	+41.10%
2020-06-30	AU$7.75 Million ≈ $5.49 Million	+19.93%
2019-06-30	AU$6.46 Million ≈ $4.57 Million	+23.50%
2018-06-30	AU$5.23 Million ≈ $3.70 Million	-6.65%
2017-06-30	AU$5.61 Million ≈ $3.97 Million	-41.68%
2016-06-30	AU$9.62 Million ≈ $6.80 Million	+40.88%
2015-06-30	AU$6.83 Million ≈ $4.83 Million	+74.51%
2014-06-30	AU$3.91 Million ≈ $2.77 Million	+51.47%
2013-06-30	AU$2.58 Million ≈ $1.83 Million	-54.03%
2012-06-30	AU$5.62 Million ≈ $3.97 Million	+165.70%
2011-06-30	AU$2.11 Million ≈ $1.50 Million	-22.37%
2010-06-30	AU$2.72 Million ≈ $1.93 Million	-18.67%
2009-06-30	AU$3.35 Million ≈ $2.37 Million	-21.59%
2008-06-30	AU$4.27 Million ≈ $3.02 Million	-9.14%
2007-06-30	AU$4.70 Million ≈ $3.33 Million	+27.11%
2006-06-30	AU$3.70 Million ≈ $2.62 Million	+45.91%
2005-06-30	AU$2.53 Million ≈ $1.79 Million	+182.02%
2004-06-30	AU$898.45K ≈ $635.71K	-38.98%
2003-06-30	AU$1.47 Million ≈ $1.04 Million	-7.58%
2002-06-30	AU$1.59 Million ≈ $1.13 Million	+43.55%
2001-06-30	AU$1.11 Million ≈ $785.26K	+456.90%
2000-06-30	AU$199.28K ≈ $141.00K	--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$150.21 Million

AU$212.29 Million AUD

Market Cap Rank

#17394 Global

#508 in Australia

Share Price

AU$0.45

Change (1 day)

-3.26%

52-Week Range

AU$0.32 - AU$0.87

All Time High

AU$2.49